CleanSpark Inc vs Regeneron Pharmaceuticals Inc — how do they compare? CleanSpark Inc trades at $11.9 (market cap $2.96B), while Regeneron Pharmaceuticals Inc trades at $796.38 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 27.7× CleanSpark Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.47% dividend while CleanSpark Inc pays none. Which is the better fit depends on your goals.
| CLSK | REGN | |
|---|---|---|
Market Cap | $2.96B | $82.06B |
Sector | Technology | Health |
52-Week High | $23.20 | $812.27 |
52-Week Low | $8.18 | $555.51 |
Enterprise Value | $3.95B | $76.77B |
Dividend Yield | — | 0.47% |
Trailing returns across standard periods
Latest headlines on both assets
CleanSpark is a leading Bitcoin mining company that operates high-density data centers. It focuses on using sustainable energy to power its mining fleet and provides digital infrastructure for the blockchain ecosystem.
Read more on CLSK →Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →